Surface Oncology surges on $30 mln milestone payment
31/03/2022 12:52
** Drug developer's shares SURF.O up 11% at $3.13 before
the bell
** Says to get a $30 million milestone payment from
GlaxoSmithKline GSK.L after first patient dosed in a trial
testing experimental treatment for solid tumors urn:newsml:reuters.com:*:nGNX5dK6zS
** SURF and GSK entered licensing agreement in 2020 over
immunotherapy program
** Stock down 41% YTD through Wednesday close
(Reporting by Ankur Banerjee)
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing